Institutional Ownership Amylyx Pharmaceuticals, Inc. (AMLX)
This table provides information about the institutional ownership of Amylyx Pharmaceuticals, Inc. (AMLX). We have compiled data on the 184 institutions that hold shares in the stock, with a total of 94.1 Million shares, which have been reported (via 13F filing form) to have a value of $1.19 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Royal Bank Of Canada
Toronto, A6 |
Nov 14, 2025 Q3 2025 |
93,012
shares
|
$1.18 Million
0.0% of portfolio
|
Q2 2025
Added 2.39%
|
|
|
Dark Forest Capital Management LP
Weston, CT |
Nov 17, 2025 Q3 2025 |
86,795
shares
|
$1.1 Million
0.05% of portfolio
|
Q3 2025
New holding
|
|
|
Eam Investors, LLC
Solana Beach, CA |
Nov 14, 2025 Q3 2025 |
75,111
shares
|
$953,158
0.14% of portfolio
|
Q3 2025
Reduced 24.86%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
73,640
shares
|
$934,491
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2025 Q3 2025 |
71,500
shares
|
$907,335
0.0% of portfolio
|
Q3 2025
Added 133.66%
|
|
|
Maven Securities LTD
St Helier, Y9 |
Nov 20, 2025 Q3 2025 |
70,000
shares
|
$888,300
0.2% of portfolio
|
Q3 2025
New holding
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2025 Q3 2025 |
68,877
shares
|
$874,049
0.0% of portfolio
|
Q3 2025
Reduced 54.54%
|
|
|
Legal & General Group PLC
London, X0 |
Nov 13, 2025 Q3 2025 |
67,212
shares
|
$852,920
0.0% of portfolio
|
Q3 2025
Added 808.02%
|
|
|
Numerai Gp LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
67,153
shares
|
$852,171
0.13% of portfolio
|
Q3 2025
New holding
|
|
|
Verition Fund Management LLC
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
63,896
shares
|
$810,840
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Readystate Asset Management LP
Chicago, IL |
Nov 07, 2025 Q3 2025 |
59,132
shares
|
$750,385
0.03% of portfolio
|
Q3 2025
New holding
|
|
|
Brevan Howard Capital Management LP
St. Helier, Y9 |
Nov 14, 2025 Q3 2025 |
56,667
shares
|
$719,104
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Russell Investments Group, Ltd.
|
Nov 13, 2025 Q3 2025 |
55,406
shares
|
$703,102
0.0% of portfolio
|
Q3 2025
Added 789.48%
|
|
|
Gsa Capital Partners LLP
London, X0 |
Nov 07, 2025 Q3 2025 |
52,107
shares
|
$661,237
0.06% of portfolio
|
Q3 2025
Reduced 69.44%
|
|
|
Mariner, LLC
Overland Park, KS |
Nov 14, 2025 Q3 2025 |
48,027
shares
|
$609,462
0.0% of portfolio
|
Q3 2025
Reduced 1.32%
|
|
|
Hennion & Walsh Asset Management, Inc.
|
Oct 22, 2025 Q3 2025 |
47,898
shares
|
$607,825
0.03% of portfolio
|
Q3 2025
Reduced 15.72%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
43,637
shares
|
$553,753
0.0% of portfolio
|
Q3 2025
Reduced 93.25%
|
|
|
Met Life Investment Management, LLC
Whippany, NJ |
Nov 13, 2025 Q3 2025 |
42,929
shares
|
$544,769
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Td Asset Management Inc
|
Nov 10, 2025 Q3 2025 |
40,966
shares
|
$519,858
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Citigroup Inc
|
Nov 10, 2025 Q3 2025 |
38,083
shares
|
$483,273
0.0% of portfolio
|
Q3 2025
Added 22.46%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
36,643
shares
|
$464,999
0.0% of portfolio
|
Q1 2024
Reduced 3.7%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
35,844
shares
|
$454,860
0.0% of portfolio
|
Q3 2025
Reduced 33.71%
|
|
|
Mirae Asset Global Etfs Holdings Ltd.
Central, K3 |
Nov 14, 2025 Q3 2025 |
31,999
shares
|
$406,067
0.0% of portfolio
|
Q3 2025
Reduced 15.76%
|
|
|
Monashee Investment Management LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
30,000
shares
|
$380,700
0.65% of portfolio
|
Q3 2025
New holding
|
|
|
Quadrature Capital LTD
London, X0 |
Nov 13, 2025 Q3 2025 |
28,286
shares
|
$358,949
0.0% of portfolio
|
Q3 2025
Reduced 3.89%
|
|